Curis to Present at UBS Global Life Science Conference
Wednesday September 17, 8:42 am ET
CAMBRIDGE, Ma.--(BUSINESS WIRE)--Sept. 17, 2003--Curis, Inc. (NASDAQ: CRIS - News) announced today that Dr. Marc Charette, Vice President of Corporate Communications, will speak at the upcoming UBS Global Life Sciences conference being held at the Plaza Hotel in New York City on September 22-25, 2003. Dr. Charette's presentation is scheduled for 9:30 AM on September 23. He will present an update on Curis' therapeutic product development programs and the company's future plans for partnering.
A live audio webcast will be available on the UBS website. You can access the webcast by going to the UBS homepage at www.ibb.ubs.com and clicking on Conferences in the middle of the page. Follow the link for Webcast under the Global Life Sciences Conference heading. The webcast will be archived for thirty days.
The UBS Global Life Sciences Conference is held annually and provides a forum for life science companies to meet with investors. It is expected that 350 biotechnology and medical technology companies will present at the conference.
About Curis, Inc.
Curis, Inc. is a therapeutic drug development company. The Company's technology focus is on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of kidney disease, neurological disorders, cancer, and alopecia (hair loss). For more information, please visit the Curis web site at www.curis.com.
Contact:
Curis, Inc.
Christopher U. Missling, Ph.D., 617-503-6587
Marc F. Charette, Ph.D., 617-503-6629
Source: Curis, Inc. |
